Are Two Mutations Sufficient to Cause Cancer? Some Generalizations of the Two-Mutation Model of Carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the Multistage Model of Armitage and Doll
From MaRDI portal
Publication:4335620
DOI10.2307/2533259zbMath0899.62137OpenAlexW4291673854WikidataQ53459456 ScholiaQ53459456MaRDI QIDQ4335620
Publication date: 12 June 1997
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2533259
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items
Evolutionary dynamics of invasion and escape, A two-phase Poisson process model and its application to analysis of cancer mortality among A-bomb survivors, New stochastic carcinogenesis model with covariates: an approach involving intracellular barrier mechanisms, Combined effect of multiple carcinogens and synergy index, A multi-compartment cell repopulation model allowing for inter-compartmental migration following radiation exposure, applied to leukaemia, Incorporating observability thresholds of tumors into the two-stage carcinogenesis model, Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations, On a trinity role of the survival and hazard functions of the two-stage carcinogenesis models, Statistical advances in environmental science, The death-mutation model of carcinogenesis, Stochastic modeling of carcinogenesis by state space models: a new approach, Modelling and data analysis in cancer studies. Papers of the international conference on carcinogenesis modeling and risk assessment, Park City, UT, USA, Summer 1998, A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data, A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data, Stochastic modeling of carcinogenesis: Some new insights, Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions
